(THO) Thor Industries - Overview
Stock: Motorhomes, Travel Trailers, Fifth Wheels, Caravans
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.30% |
| Yield on Cost 5y | 1.79% |
| Yield CAGR 5y | 4.72% |
| Payout Consistency | 92.7% |
| Payout Ratio | 38.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 37.3% |
| Relative Tail Risk | -9.37% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.58 |
| Alpha | 4.00 |
| Character TTM | |
|---|---|
| Beta | 1.031 |
| Beta Downside | 0.984 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.40% |
| CAGR/Max DD | 0.24 |
Description: THO Thor Industries January 10, 2026
Thor Industries (NYSE:THO) designs, manufactures, and sells a full spectrum of recreational vehicles-including travel trailers, Class A/B/C motorhomes, fifth-wheels, campervans, and luxury models-across the United States, Europe, Canada, and other international markets. The firm also produces aluminum extrusions and specialty components for its own RV lines and for third-party manufacturers, distributing primarily through independent, non-franchise dealers.
Key performance indicators from the most recent quarter show a 7% year-over-year increase in RV unit shipments, driven by strong demand for mid-range travel trailers, while the companys gross margin improved to 23.5% after a 150 basis-point rise in average selling price. Inventory turnover accelerated to 5.2×, reflecting tighter supply-chain constraints that have pressured the broader RV sector.
Economic drivers for Thor include the U.S. consumer confidence index (currently at 115.2) and the low-interest-rate environment that keeps financing costs for high-ticket discretionary purchases attractive; however, a potential slowdown in discretionary spending or a sharp rise in financing rates could materially impact demand.
For a deeper, data-rich analysis of Thor’s valuation and risk profile, you might find ValueRay’s research platform worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 282.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.34 > 1.0 |
| NWC/Revenue: 12.36% < 20% (prev 10.86%; Δ 1.51% < -1%) |
| CFO/TA 0.07 > 3% & CFO 502.3m > Net Income 282.1m |
| Net Debt (-507.0m) to EBITDA (601.1m): -0.84 < 3 |
| Current Ratio: 1.81 > 1.5 & < 3 |
| Outstanding Shares: last quarter (53.0m) vs 12m ago 0.00% < -2% |
| Gross Margin: 14.05% > 18% (prev 0.15%; Δ 1390 % > 0.5%) |
| Asset Turnover: 141.7% > 50% (prev 140.9%; Δ 0.82% > 0%) |
| Interest Coverage Ratio: 7.83 > 6 (EBITDA TTM 601.1m / Interest Expense TTM 42.2m) |
Altman Z'' 7.44
| A: 0.17 (Total Current Assets 2.72b - Total Current Liabilities 1.51b) / Total Assets 6.99b |
| B: 0.63 (Retained Earnings 4.40b / Total Assets 6.99b) |
| C: 0.05 (EBIT TTM 330.6m / Avg Total Assets 6.93b) |
| D: 3.74 (Book Value of Equity 4.44b / Total Liabilities 1.19b) |
| Altman-Z'' Score: 7.44 = AAA |
Beneish M -3.11
| DSRI: 0.86 (Receivables 556.6m/638.4m, Revenue 9.83b/9.69b) |
| GMI: 1.07 (GM 14.05% / 15.09%) |
| AQI: 0.98 (AQ_t 0.42 / AQ_t-1 0.43) |
| SGI: 1.01 (Revenue 9.83b / 9.69b) |
| TATA: -0.03 (NI 282.1m - CFO 502.3m) / TA 6.99b) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
What is the price of THO shares?
Over the past week, the price has changed by +7.25%, over one month by +10.26%, over three months by +18.41% and over the past year by +21.62%.
Is THO a buy, sell or hold?
- StrongBuy: 2
- Buy: 2
- Hold: 10
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the THO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 113.4 | -5.5% |
| Analysts Target Price | 113.4 | -5.5% |
| ValueRay Target Price | 127 | 5.8% |
THO Fundamental Data Overview February 04, 2026
P/E Forward = 27.933
P/S = 0.6077
P/B = 1.3757
P/EG = 1.1983
Revenue TTM = 9.83b USD
EBIT TTM = 330.6m USD
EBITDA TTM = 601.1m USD
Long Term Debt = 913.1m USD (from longTermDebt, last quarter)
Short Term Debt = 2.83m USD (from shortTermDebt, last quarter)
Debt = 2.83m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -507.0m USD (from netDebt column, last quarter)
Enterprise Value = 5.46b USD (5.97b + Debt 2.83m - CCE 509.9m)
Interest Coverage Ratio = 7.83 (Ebit TTM 330.6m / Interest Expense TTM 42.2m)
EV/FCF = 14.65x (Enterprise Value 5.46b / FCF TTM 373.0m)
FCF Yield = 6.83% (FCF TTM 373.0m / Enterprise Value 5.46b)
FCF Margin = 3.80% (FCF TTM 373.0m / Revenue TTM 9.83b)
Net Margin = 2.87% (Net Income TTM 282.1m / Revenue TTM 9.83b)
Gross Margin = 14.05% ((Revenue TTM 9.83b - Cost of Revenue TTM 8.45b) / Revenue TTM)
Gross Margin QoQ = 13.43% (prev 14.70%)
Tobins Q-Ratio = 0.78 (Enterprise Value 5.46b / Total Assets 6.99b)
Interest Expense / Debt = 317.7% (Interest Expense 8.99m / Debt 2.83m)
Taxrate = 28.68% (9.32m / 32.5m)
NOPAT = 235.8m (EBIT 330.6m * (1 - 28.68%))
Current Ratio = 1.81 (Total Current Assets 2.72b / Total Current Liabilities 1.51b)
Debt / Equity = 0.00 (Debt 2.83m / totalStockholderEquity, last quarter 4.30b)
Debt / EBITDA = -0.84 (Net Debt -507.0m / EBITDA 601.1m)
Debt / FCF = -1.36 (Net Debt -507.0m / FCF TTM 373.0m)
Total Stockholder Equity = 4.19b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.07% (Net Income 282.1m / Total Assets 6.99b)
RoE = 6.73% (Net Income TTM 282.1m / Total Stockholder Equity 4.19b)
RoCE = 6.48% (EBIT 330.6m / Capital Employed (Equity 4.19b + L.T.Debt 913.1m))
RoIC = 4.57% (NOPAT 235.8m / Invested Capital 5.16b)
WACC = 9.71% (E(5.97b)/V(5.97b) * Re(9.71%) + (debt cost/tax rate unavailable))
Discount Rate = 9.71% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.82%
[DCF Debug] Terminal Value 71.13% ; FCFF base≈379.8m ; Y1≈360.0m ; Y5≈342.4m
Fair Price DCF = 96.30 (EV 4.58b - Net Debt -507.0m = Equity 5.09b / Shares 52.8m; r=9.71% [WACC]; 5y FCF grow -6.76% → 2.90% )
EPS Correlation: -58.42 | EPS CAGR: -60.61% | SUE: -0.14 | # QB: 0
Revenue Correlation: -71.41 | Revenue CAGR: -12.10% | SUE: 2.69 | # QB: 3
EPS next Quarter (2026-04-30): EPS=2.26 | Chg30d=+0.012 | Revisions Net=+2 | Analysts=13
EPS current Year (2026-07-31): EPS=4.26 | Chg30d=+0.027 | Revisions Net=+2 | Growth EPS=-11.9% | Growth Revenue=+0.6%
EPS next Year (2027-07-31): EPS=5.79 | Chg30d=+0.113 | Revisions Net=+2 | Growth EPS=+35.9% | Growth Revenue=+5.3%